Cat Autoimmune Disease: Symptoms & Treatment

Autoimmune diseases in cats are relatively uncommon but can be serious, complex, and challenging to diagnose and manage. When a cat develops an autoimmune disease, the immune system—which normally protects against infections and foreign invaders—becomes dysregulated and mistakenly attacks the cat's own cells and tissues. Unlike infectious diseases that can be eliminated once the pathogen is destroyed, autoimmune diseases are chronic conditions that cannot be cured but can often be managed effectively to maintain reasonable quality of life. Understanding what autoimmune diseases are, recognising the various types that affect cats, identifying warning signs, understanding why diagnosis is challenging, knowing what treatment options exist, and learning how to support a cat living with autoimmune disease, is essential knowledge for cat owners who may encounter these conditions.

The diagnosis and management of feline autoimmune disease requires patience, veterinary expertise, and owner commitment to long-term care. Early recognition and intervention significantly improve outcomes and quality of life. While some autoimmune conditions, such as pemphigus foliaceus, are more commonly diagnosed, others, including systemic lupus erythematosus, remain rare in cats. This comprehensive guide explains how the immune system normally functions, describes what happens when it becomes dysregulated, explores the most common autoimmune diseases affecting cats, details diagnostic approaches, discusses treatment options and prognosis, and provides guidance on managing these complex conditions long-term.

Understanding the Immune System and Autoimmunity

How the Normal Immune System Works

The cat's immune system is an intricate biological network designed to protect against infections, foreign invaders, and harmful substances. It accomplishes this through multiple mechanisms and specialised cells.

Components of the Immune System:

• Antibodies (immunoglobulins): Protein molecules that recognise and bind to foreign invaders (antigens), marking them for destruction
• White blood cells: Specialised cells including lymphocytes (T cells and B cells), macrophages, and others that actively attack and destroy pathogens
• Lymphoid tissues: Organs including lymph nodes, spleen, and thymus where immune cells develop and activate
• Immune regulation: Mechanisms that distinguish between "self" (the body's own cells) and "non-self" (foreign invaders), preventing the immune system from attacking the body's own tissues

What Goes Wrong in Autoimmune Disease

In autoimmune disease, the regulatory mechanisms fail and the immune system loses the ability to distinguish self from non-self. The immune system then attacks the body's own cells and tissues as if they were dangerous invaders.

The Pathological Process:

• Loss of tolerance: The immune system loses the regulatory ability to tolerate the body's own cells
• Production of auto-antibodies: B cells produce antibodies (auto-antibodies) that bind to and attack the body's own tissues
• T cell attack: T cells, which normally kill infected or abnormal cells, attack healthy cells
• Inflammatory response: The immune attack triggers inflammation, tissue damage, and destruction of affected structures
• Chronic disease: Unlike infections that can be eliminated, autoimmune disease persists because the immune system continues attacking the body's own tissues

Common Autoimmune Diseases in Cats

1. Pemphigus Foliaceus (Skin Disease)

Pemphigus foliaceus is the most commonly diagnosed autoimmune disease in cats. It is a chronic autoimmune condition affecting the skin.

What Happens:

• Auto-antibody attack: The immune system produces auto-antibodies that attack desmosomal proteins (proteins that help skin cells stick together)
• Cellular breakdown (acantholysis): Skin cells lose their adhesion and separate, leading to formation of blisters and erosions
• Surface-level involvement: The disease primarily affects the superficial layers of the skin

Clinical Presentation:

• Typical locations: Lesions commonly appear on the face (especially around the nose and eyes), ears (especially concave surfaces), paws (particularly footpads and nail beds), groin area, and around nipples
• Types of lesions: Crusts (yellow to brown, adherent crusts), erosions (shallow ulcers), pustules (pus-filled lesions), scabs, and areas of hair loss
• Associated symptoms: Itching or discomfort, pain when lesions are touched, secondary bacterial infections
• Systemic signs: May occur but are not primary; some cats show lethargy or loss of appetite if secondary infections develop

Diagnosis:

• Skin biopsy: Definitive diagnosis requires microscopic examination of affected skin tissue showing characteristic histopathological findings
• Procedure: Small round samples of skin are removed using a biopsy punch, usually under local or general anaesthesia
• Pathologist examination: Tissue is examined under a microscope to identify the characteristic pattern of acantholysis

Prognosis and Management:

• No cure: Pemphigus foliaceus cannot be cured but can be effectively managed
• Time to control: Average time to disease control is approximately 3 weeks with appropriate treatment
• Long-term treatment: Most cats require lifelong immunosuppressive medication to maintain remission
• Relapse risk: High risk of relapse if treatment is stopped or reduced without veterinary guidance
• Response to treatment: Most cats respond well to appropriate immunosuppressive therapy; many can achieve good quality of life with proper management

2. Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus is a multisystem autoimmune disease that can affect multiple organs throughout the body. It is rare in cats but more serious than localised autoimmune diseases.

What Happens:

• Widespread auto-antibodies: The immune system produces auto-antibodies against multiple tissues and organs
• Multi-organ involvement: Any organ system can be affected including skin, joints, kidneys, heart, lungs, and blood cells
• Abnormal immune regulation: Results from dysregulation of the immune system with failure of normal tolerance mechanisms

Affected Systems:

• Skin: Lupus skin lesions (approximately 60% of affected cats have skin lesions); particularly on the nose with characteristics similar to nasal cutaneous lupus
• Joints: Lupus arthritis causing joint inflammation, lameness, and stiffness
• Kidneys: Glomerulonephritis (inflammation of kidney filtration units); can lead to proteinuria (protein in urine) and eventual kidney failure
• Blood cells: Immune-mediated destruction of red blood cells (haemolytic anaemia) or platelets (thrombocytopenia)
• Other organs: Heart, lungs, and other organs can be affected

Clinical Signs:

• Skin lesions: Ulcers, sores, scabs, or redness, particularly on the face and ears
• Joint pain and lameness: Due to arthritis
• Fever: Intermittent or persistent fever
• Lethargy and malaise: General feelings of illness
• Weight loss: Due to systemic illness
• Symptoms from organ involvement: Depending on which organs are affected

Diagnosis:

• Complex diagnosis: Requires multiple tests and often diagnosis of exclusion
• Antinuclear antibody (ANA) test: Positive in most SLE cases; detects anti-nuclear antibodies
• Clinical criteria: Diagnosis usually requires positive ANA test plus at least two clinical entities (e.g., skin lesions, joint disease, kidney involvement)
• Additional testing: Biopsies, kidney function tests, blood work
• Breed predisposition: Siamese, Persian, and Persian crosses are more commonly affected

Prognosis:

• Rarity: Lupus is rare in cats; most veterinarians see very few cases
• Variable prognosis: Depends on which organs are affected and severity of involvement
• Management possible: Many cats can be managed with appropriate treatment and monitoring

3. Immune-Mediated Haemolytic Anaemia (IMHA)

IMHA occurs when the immune system attacks and destroys red blood cells. This results in anaemia ranging from mild to life-threatening.

What Happens:

• Auto-antibody attack: Auto-antibodies bind to red blood cells, marking them for destruction
• Red blood cell destruction: The spleen and other immune tissues remove and destroy antibody-coated red blood cells
• Anaemia development: As red blood cells are destroyed faster than the body can replace them, anaemia develops

Clinical Signs:

• Pale gums and mucous membranes: Due to reduced haemoglobin
• Lethargy and weakness: Due to reduced oxygen-carrying capacity
• Rapid or laboured breathing: Body attempts to increase oxygen delivery
• Jaundice (yellow discolouration): If haemolysis (red blood cell destruction) is severe
• Loss of appetite: General malaise
• Elevated heart rate: Compensatory response to reduced blood oxygen

4. Other Autoimmune Conditions

Immune-Mediated Thrombocytopenia (IMTP):

• What happens: Immune system attacks platelets (blood cells essential for clotting)
• Clinical signs: Excessive bleeding, bruising, bloody urine or faeces, bleeding gums
• Diagnosis: Low platelet count on blood work

Feline Progressive Polyarthritis:

• What happens: Autoimmune inflammation of multiple joints
• Clinical signs: Joint pain, lameness, swelling, stiffness (erosive or non-erosive)
• Affected joints: Joints of limbs, spine, and other locations

Immune-Mediated Glomerulonephritis:

• What happens: Immune system targets kidney glomeruli (filtering units)
• Clinical signs: Protein loss in urine, weight loss, lethargy, potential progression to kidney failure

Lymphocytic Plasmacytic Stomatitis:

• What happens: Abnormal immune response causes mouth and gum inflammation
• Clinical signs: Excessive drooling, difficulty eating, bad breath, mouth pain
• Severity: Can be debilitating; some cats are unable to eat normally

Causes and Risk Factors

Idiopathic (No Known Cause)

In many cats with autoimmune disease, the exact cause remains unknown; these cases are termed idiopathic. Pemphigus foliaceus is mostly idiopathic, meaning a specific trigger cannot be identified.

Potential Triggers and Risk Factors

Genetic Predisposition:

• Breed association: Siamese, Persian, and Persian crosses are more commonly affected with certain autoimmune conditions
• Familial clustering: Some autoimmune conditions appear to run in families
• Genetic susceptibility: Certain genetic factors increase risk of immune dysregulation

Infections:

• Trigger hypothesis: Some infections may trigger development of autoimmune disease in genetically predisposed cats
• Molecular mimicry: Infectious agents may resemble the cat's own tissues, triggering cross-reactive immune responses

Medications:

• Drug-induced autoimmunity: Some medications have been implicated in triggering or exacerbating autoimmune disease
• Pemphigus foliaceus: Certain drugs may be involved in triggering this condition in susceptible cats
• Drug-triggered vs. drug-induced: Some drug-related cases resolve when the medication is stopped; others require continued treatment

Environmental Factors:

• UV exposure: Nasal cutaneous lupus may be worsened by sun exposure; some cats show improved lesions with reduced UV exposure
• Other environmental triggers: Stress, diet, or other factors may play a role in susceptible individuals (largely unproven)

Diagnosis of Autoimmune Disease

Why Diagnosis Is Challenging

Autoimmune disease diagnosis is complex because it is diagnosis of exclusion; other conditions must be ruled out first.

• Many mimics: Many other diseases present with similar symptoms to autoimmune disease
• Rarity: These conditions are relatively uncommon; many veterinarians see few cases
• Multiple tests needed: No single test definitively diagnoses most autoimmune conditions
• Time-consuming: Diagnosis often requires multiple visits and testing rounds

Diagnostic Tests

Blood Work:

• Complete blood count (CBC): Evaluates red and white blood cell counts; low red blood cells suggest IMHA; low platelets suggest IMTP
• Chemistry panel: Assesses organ function including kidney function (relevant for SLE and glomerulonephritis)
• Antinuclear antibody (ANA) test: Positive in systemic lupus erythematosus
• Reticulocyte count: Assesses bone marrow response to anaemia (elevated in IMHA)

Skin Biopsy:

• Gold standard: Definitive diagnosis of pemphigus foliaceus and lupus skin disease requires skin biopsy
• Histopathology: Tissue examined under microscope by veterinary pathologist
• Immunopathology: Special staining shows immune deposits and antibody binding patterns

Urine Tests:

• Urinalysis: Detects protein loss (proteinuria) seen in glomerulonephritis; may show casts or other abnormalities

Imaging:

• X-rays or ultrasound: Assess for organ involvement; particularly important if systemic lupus or glomerulonephritis is suspected

Process of Diagnosis

Diagnosis typically involves a systematic approach of ruling out other conditions while pursuing supportive evidence for autoimmune disease.

• Step 1 – Rule out infectious causes: Infections, parasites, fungal disease
• Step 2 – Rule out other common conditions: Allergies, neoplasia, other systemic diseases
• Step 3 – Gather supportive evidence: Appropriate blood work, biopsies, ANA testing
• Step 4 – Clinical and pathological correlation: Clinical signs, diagnostic findings, and response to initial treatment inform diagnosis

Treatment of Autoimmune Disease

Goals of Treatment

Treatment aims to suppress the abnormal immune response, reduce inflammation, and manage symptoms while maintaining acceptable quality of life. Cure is not possible, but remission and control are achievable goals.

Immunosuppressive Medications

Corticosteroids (Glucocorticoids):

• Most common treatment: Corticosteroids are the primary treatment for most feline autoimmune diseases
• Common medication: Prednisolone is the most commonly used corticosteroid in cats
• Mechanism: Reduces immune cell activation and inflammation
• Dosing: Higher doses initially to suppress disease; gradually reduced to minimum effective dose
• Side effects: Increased appetite, weight gain, increased thirst and urination, increased susceptibility to infections, behaviour changes (long-term use)
• Monitoring: Requires regular veterinary monitoring and blood work

Other Immunosuppressive Medications:

• Ciclosporin: Calcineurin inhibitor; suppresses T cell function; may be used as alternative or in combination with corticosteroids
• Chlorambucil: Cytotoxic immunosuppressive agent; used in some difficult-to-control cases
• Gold salts: Rarely used but have immunosuppressive properties
• Azathioprine: Purine antagonist; rarely used in cats due to toxicity concerns

Supportive Care

• Infection management: Antibiotic treatment for secondary bacterial infections that develop on damaged skin
• Pain management: Appropriate pain relief for conditions like arthritis
• Topical treatments: Medicated shampoos, topical corticosteroids for skin lesions
• Dietary management: High-quality, appropriate diet supports healing and general health
• Environmental management: Sun avoidance for lupus (particularly nasal lesions), stress reduction

Long-Term Management and Quality of Life

Lifelong Commitment

Most cats with autoimmune disease require lifelong treatment and monitoring. This involves consistent medication administration, regular veterinary visits, and vigilance for complications.

Management Requirements:

• Consistent medication: Strict adherence to prescribed treatment; missed doses can trigger relapse
• Regular veterinary visits: Periodic examinations and blood work monitor disease control and medication side effects
• Disease monitoring: Watch for signs of flare-ups or worsening; report to veterinarian immediately
• Medication adjustments: Treatment may need adjustment over time based on disease activity and side effects

Prognosis and Quality of Life

With appropriate treatment and management, most cats with autoimmune disease can achieve good quality of life.

• Pemphigus foliaceus: Prognosis is considered good; most cats respond well to treatment and can be managed effectively
• IMHA: Prognosis varies depending on severity; many cats survive the acute phase and achieve remission
• SLE: Prognosis depends on organ involvement; some cats do well, others have more serious outcomes
• Overall: Many cats achieve remission or control where they live relatively normal lives with medications and veterinary monitoring

Complications to Watch For

• Secondary infections: Immunosuppressive therapy increases infection risk; monitor for signs of infection
• Medication side effects: Particularly with long-term corticosteroid use
• Disease flare-ups: Periods of worsening disease activity; may occur without warning
• Organ damage: Particularly with systemic conditions like SLE affecting kidneys or heart

This guide is based on research from PetMD, VCA Animal Hospitals, Catster, Kingsdale Animal Hospital, Whisker, Country Vet Mom, NIH/PMC (National Institutes of Health/PubMed Central), and peer-reviewed veterinary literature. Pemphigus foliaceus is the most commonly reported autoimmune disease in cats; most affected cats are middle-aged (5-8 years) with no clear breed or gender predisposition (though some breed associations reported in certain forms). Skin biopsy diagnosis requires identifying characteristic histopathological findings of acantholysis (separation of skin cells due to loss of adhesion proteins). Treatment requires average of approximately 3 weeks to achieve disease control; prognosis is considered good with most cats responding to immunosuppressive therapy. High relapse risk exists during treatment adjustments or if medication is stopped; some drug-associated pemphigus cases may resolve upon medication cessation, but most require long-term ongoing treatment. Systemic lupus erythematosus, while rare in cats, has been documented with variable clinical presentations; diagnosis based on positive antinuclear antibody test combined with characteristic clinical and histopathological findings; Siamese, Persian, and Persian crosses show increased predisposition. Pemphigus foliaceus primarily affects superficial skin layers (intraepidermal blistering); histopathology shows characteristic acantholytic pattern and immune deposits. Time to disease control average 3 weeks; relapse risk remains high throughout life if immunosuppressive treatment is discontinued. Prognosis is good but requires lifelong commitment to treatment and monitoring. Secondary bacterial infections common complication of autoimmune skin disease; must be appropriately treated concurrent with immunosuppressive therapy.